|
|
Board of Directors
Lihu Avitov - Executive Vice President, Ofer Hi-Tech Group
Mr. Avitov heads life sciences investments in the Ofer Hi-Tech Group and was previously the CEO of Naiot Technological Center. Mr. Avitov holds a BA in economics and management and an MSc in industrial engineering and management from the Technion.
Ronit Bendori - General Partner, Evergreen Venture Partners
Dr. Bendori is a general partner at Evergreen Venture Partners, responsible for health care investments of the fund. She serves on the boards of Transpharma Medical, Activiews, NiTi Surgical Solutions Vascure and Procognia. She was the chairperson of Colbar which was acquired in 2006 by J&J. She is a former vice president of Pharmos Ltd, and has held senior positions at InterPharm Ltd (Israel) and Ares-Sereno (Switzerland). Dr. Bendori holds a Ph.D in molecular Biology from the Weizmann Institute of Science
Boaz Goldschmidt - Partner, Yozma Management and Investments
Mr. Goldschmidt was the co-founder of Yozma Venture Capital and the core of its management team since its inception in January 1993. Mr. Goldschmidt led many of Yozma's investments, including InStent (NASDAQ: ININ) and Influence (acquired by American Medical Systems Inc.). He holds a BA in economics and an MBA from the Hebrew University of Jerusalem.
Yair Feld - GeneGrafts Ltd
Dr. Feld is a co-founder of CorAssist and currently heads GeneGrafts, a startup company developing a gene therapy approach for the treatment of atrial fibrillation. Dr. Feld holds an MD and PhDs in physiology and biophysics from the Technion.
Dan Gelvan - Managing Director, Aurum Ventures MKI Ltd.
Dr Gelvan is the Managing Director of Life Sciences, Aurum Ventures MKI Ltd. He is a seasoned life-science executive who before joining Aurum Ventures managed GammaCan International, Inc., a development-stage pharmaceutical company. Previously, Dr Gelvan founded and managed Zetiq Technologies, a drug discovery company specializing in cell-based high-throughput screening for novel anti-cancer drugs. Dr Gelvan founded Zetiq after leaving a senior position in Clal (Israel) Ltd., one of Israel's largest holding conglomerates. Dr Gelvan holds a PhD in Business Economics from RUC in Denmark and he is an experienced lecturer of corporate finance and entrepreneurship. Dr Gelvan is a member of Israel's National Committee for Biotechnology.
John Young - Vice President, Argonaut Private Equity
John Young is a Vice President at Argonaut Private Equity, a global private equity fund based in Tulsa, Oklahoma. Since joining Argonaut in 2004, Mr. Young has invested in approximately 20 privately-held companies in industries as diverse as industrial manufacturing, telecommunications, real-time operating systems, GPS guidance systems, interactive surveillance, drug delivery, semiconductors, medical equipment, and solar power.
Prior to Argonaut, Mr. Young held senior management positions in the telecommunications and video multimedia industries leading teams in mergers and acquisitions, investments, marketing, operations, and product development.
Mr. Young earned a bachelor’s degree from SMU in Dallas, Texas and an MBA from the University of Tulsa.
|
